TurboHawk Helps Drive Q4 Peripheral Vascular Sales Growth At ev3
This article was originally published in The Gray Sheet
Executive Summary
Device maker ev3's peripheral vascular sales advanced 8% to $73.7 million in the fourth quarter, driven by the new TurboHawk plaque excision system